Compare Iron Mountain Inc (IRM) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Iron Mountain Inc vs Zoetis Inc — how do they compare? Iron Mountain Inc trades at $114.51 (market cap $34.46B), while Zoetis Inc trades at $74.77 (market cap $30.20B). The key difference: Iron Mountain Inc and Zoetis Inc are close in size by market cap, and Iron Mountain Inc pays the higher dividend (2.99%). Which is the better fit depends on your goals — on Pluang, investors hold Iron Mountain Inc for 80 Days and Zoetis Inc for 70 Days on average.
| IRM | ZTS | |
|---|---|---|
Market Cap | $34.46B | $30.20B |
Volume | 1,379,608 | 6,175,327 |
Sector | Real Estate | Health |
52-Week High | $133.06 | $147.53 |
52-Week Low | $78.86 | $69.09 |
Typical Hold Time | 80 Days | 70 Days |
Enterprise Value | $53.87B | $37.76B |
Dividend Yield | 2.99% | 2.9% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Iron Mountain (IRM) trades at $112.97, down 2.38% with a bearish technical signal. The company shows strong revenue growth from $6.9B in 2025 to $7.6B projected for 2026, though net margins remain thin at 2.09%. Recent earnings beats and a 300MW data center pipeline expansion highlight growth initiatives. Analyst consensus is bullish with a $142.75 price target, representing 26% upside potential from current levels.
IRM offers compelling growth in data center and digital services but carries significant debt risk with 79.04% debt-to-asset ratio. The stock presents opportunity for investors seeking exposure to digital infrastructure expansion, though high leverage and thin margins require careful monitoring. Current technical weakness may provide entry points for long-term investors aligned with analyst optimism.
Zoetis (ZTS) trades at $73.08, up 2.14% today, with a bullish technical signal despite mixed moving averages and oscillators. The company shows strong profitability with a 27.69% net income margin and 64.91% ROE, though recent quarterly earnings have been inconsistent. Analyst consensus is a $87.33 price target with no sell ratings. Recent news highlights near-term headwinds in U.S. companion animal sales but underscores long-term resilience and undervaluation.
ZTS presents a compelling value opportunity with a low P/E of 11.92 and robust margins, but faces risks from competitive pressures and volatile earnings. Upside potential exists if the company executes on international growth and maintains its industry-leading profitability, though investors should monitor Q3 2026 results for confirmation of recovery trends.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Iron Mountain Inc
Iron Mountain Inc is a record management services provider. The firm is organized as a REIT. Most of its revenue comes from its storage business, with the rest coming from value-added services. The firm primarily caters to enterprise clients in developed markets. Its business segments include Global RIM Business
Read more on IRM →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
